Fig. 4. Pathogenesis in gastrointestinal (GI) dysmotility and metabolic disorder. AHR, aryl hydrocarbon receptor; ENS, enteric nervous system; GLP-1, glucagon-like peptide-1.

J Neurogastroenterol Motil 2021;27:19~34 https://doi.org/10.5056/jnm20149

© J Neurogastroenterol Motil